Aromatase and COX in breast cancer: Enzyme inhibitors and beyond

Journal of Steroid Biochemistry and Molecular Biology

Volumn 106, Issue 1-5, 2007, Pages 16-23

  Brueggemeier, Robert W ^a   Su, Bin ^a   Sugimoto, Yasuro ^a   Díaz Cruz, Edgar S ^a   Davis, Danyetta D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Aromatase; COX 2 inhibitors; Cyclooxygenase 2; NSAIDs; Prostaglandin E2; siRNA; Sulfonanilides

Indexed keywords

ANILIDE; AROMATASE; AROMATASE INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; ESTROGEN; FORSKOLIN; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SMALL INTERFERING RNA; SULFONE DERIVATIVE;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INDICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

ANILIDES; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR STRUCTURE; RNA, MESSENGER; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34548453590     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.05.021     Document Type: Article

References (26)

1. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinshelwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., and Michael M.D. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15 (1994) 342-355
2. James V.H., McNeill J.M., Lai L.C., Newton C.J., Ghilchik M.W., and Reed M.J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50 (1987) 269-279
3. Miller W.R., and O'Neill J. The importance of local synthesis of estrogen within the breast. Steroids 50 (1987) 537-548
4. Reed M.J., Owen A.M., Lai L.C., Coldham N.G., Ghilchik M.W., Shaikh N.A., and James V.H. In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. Int. J. Cancer 44 (1989) 233-237
5. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S., and Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77 (1993) 1622-1628
6. Dowsett M., Macaulay V., Gledhill J., Ryde C., Nicholls J., Ashworth A., McKinna J.A., and Smith I.E. Control of aromatase in breast cancer cells and its importance for tumor growth. J. Steroid Biochem. Mol. Biol. 44 (1993) 605-609
7. Miller W.R., Mullen P., Sourdaine P., Watson C., Dixon J.M., and Telford J. Regulation of aromatase activity within the breast. J. Steroid Biochem. Mol. Biol. 61 (1997) 193-202
8. Reed M.J., Topping L., Coldham N.G., Purohit A., Ghilchik M.W., and James V.H. Control of aromatase activity in breast cancer cells: the role of cytokines and growth factors. J. Steroid Biochem. Mol. Biol. 44 (1993) 589-596
9. Quinn A.L., Burak W.E., and Brueggemeier R.W. Effects of matrix components on aromatase activity in breast stromal cells in culture. J. Steroid Biochem. Mol. Biol. 70 (1999) 249-256
10. Sasano H., Edwards D.P., Anderson T.J., Silverberg S.G., Evans D.B., Santen R.J., Ramage P., Simpson E.R., Bhatnagar A.S., and Miller W.R. Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J. Steroid Biochem. Mol. Biol. 86 (2003) 239-244
11. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Corbin C.J., and Mendelson C.R. Tissue-specific promoters regulate aromatase cytochrome P450 expression. J. Steroid Biochem. Mol. Biol. 44 (1993) 321-330
12. Zhao Y., Agarwal V.R., Mendelson C.R., and Simpson E.R. Transcriptional regulation of CYP19 gene (aromatase) expression in adipose stromal cells in primary culture. J. Steroid Biochem. Mol. Biol. 61 (1997) 203-210
13. Simpson E.R., Clyne C., Rubin G., Boon W.C., Robertson K., Britt K., Speed C., and Jones M. Aromatase-a brief overview. Annu. Rev. Physiol. 64 (2002) 93-127
14. Zhao Y., Agarwal V.R., Mendelson C.R., and Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137 (1996) 5739-5742
15. Hughes R., Timmermans P., and Schrey M.P. Regulation of arachidonic acid metabolism, aromatase activity and growth in human breast cancer cells by interleukin-1beta and phorbol ester: dissociation of a mediatory role for prostaglandin E2 in the autocrine control of cell function. Int. J. Cancer 67 (1996) 684-689
16. Harris R.E., Namboodiri K.K., and Farrar W.B. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology 7 (1996) 203-205
17. Harris R.E., Robertson F.M., Abou-Issa H.M., Farrar W.B., and Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med. Hypotheses 52 (1999) 291-292
18. Arun B., and Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol. 31 (2004) 22-29
19. Terry M.B., Gammon M.D., Zhang F.F., Tawfik H., Teitelbaum S.L., Britton J.A., Subbaramaiah K., Dannenberg A.J., and Neugut A.I. Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291 (2004) 2433-2440
20. Brueggemeier R.W., Quinn A.L., Parrett M.L., Joarder F.S., Harris R.E., and Robertson F.M. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 140 (1999) 27-35
21. Brodie A.M., Lu Q., Long B.J., Fulton A., Chen T., Macpherson N., DeJong P.C., Blankenstein M.A., Nortier J.W., Slee P.H., van de Ven J., van Gorp J.M., Elbers J.R., Schipper M.E., Blijham G.H., and Thijssen J.H. Aromatase and COX-2 expression in human breast cancers. J. Steroid Biochem. Mol. Biol. 79 (2001) 41-47
22. Richards J.A., and Brueggemeier R.W. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes. J. Clin. Endocrinol. Metab. 88 (2003) 2810-2816
23. Brueggemeier R.W., Diaz-Cruz E.S., Li P.K., Sugimoto Y., Lin Y.C., and Shapiro C.L. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer. J. Steroid Biochem. Mol. Biol. 95 (2005) 129-136
24. Diaz-Cruz E.S., Shapiro C.L., and Brueggemeier R.W. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J. Clin. Endocrinol. Metab. 90 (2005) 2563-2570
25. Su B., Diaz-Cruz E.S., Landini S., and Brueggemeier R.W. Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition. J. Med. Chem. 49 (2006) 1413-1419
26. Julemont F., de L.X., Michaux C., Damas J., Charlier C., Durant F., Pirotte B., and Dogne J.M. Spectral and crystallographic study of pyridinic analogues of nimesulide: determination of the active form of methanesulfonamides as COX-2 selective inhibitors. J. Med. Chem. 45 (2002) 5182-5185